Home > BIGG > Search result

    Results: 2

    Synopsis of the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: The Diagnosis and Management of Hypertension in the Primary Care Setting

    Tschanz, Mark P; Cushman, William C; Harrell, Travis E; Berlowitz, Dan R; Sall, James L.
    This guideline represents an important step toward clarifying the evidence regarding the management of patients with hypertension within the VA/DoD primary care settings. As with other clinical practice guidelines, challenges remain, such as evidence gaps, the need to develop effective strategies for gui...
    Hypertension/prevention & control, Hypertension/complications, Primary Health Care/organization & administration, Coronary Artery Disease/complications, Coronary Artery Disease/prevention & control
    Fulltext

    2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

    Macle, L; Cairns, J; Leblanc, K; Tsang, T; Skanes, A; Cox, JL; Healey, JS; Bell, A; Pilote, L; Andrade, JG; Mitchell, LB; Atzema, C; Gladstone, D; Sharma, M; Verma, S; Connolly, S; Dorian, P; Parkash, R; Talajic, M; Nattel, S; Verma, A.
    Can J Cardiol; 32 (10), 2016
    The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF pa...
    Anticoagulants, Cardiotonic Agents, Platelet Aggregation Inhibitors, Digoxin, Magnesium, Acute Coronary Syndrome/therapy, Algorithms, Anticoagulants/therapeutic use, Atrial Appendage/surgery, Atrial Fibrillation, Cardiac Pacing, Artificial, Cardiotonic Agents/adverse effects, Catheter Ablation, Cardiotonic Agents/administration & dosage, Atrial Fibrillation/therapy, Atrial Fibrillation/complications, Hemorrhage/chemically induced, Hemorrhage/prevention & control, Magnesium/therapeutic use, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors/therapeutic use, Postoperative Complications/prevention & control, ST Elevation Myocardial Infarction/therapy, Stroke/prevention & control, Coronary Artery Disease/complications, Digoxin/administration & dosage, Digoxin/adverse effects, Drug Therapy, Combination, Factor Xa Inhibitors/therapeutic use, Fibrinolytic Agents/therapeutic use, Factor Xa Inhibitors
    Fulltext